Biogen Buys Apellis for $5.6B to Expand Kidney Drugs
Bloomberg’s Michelle Davis joins Dani Burger on “Bloomberg Deals.” Biogen has agreed to acquire Apellis Pharmaceuticals for $5.6 billion, expanding…
Bloomberg’s Michelle Davis joins Dani Burger on “Bloomberg Deals.” Biogen has agreed to acquire Apellis Pharmaceuticals for $5.6 billion, expanding…
U.S. recorded music revenue hit a record high in the first half of 2025, but growth was flat year over…